GlassScriptPhysician profile
Adelina B Stateva
NPI 1477588549
$3,281.05
in general payments reported to CMS, 2019-2025
14 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $312 · 2021: $311 · 2022: $384 · 2023: $625 · 2024: $348 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,529.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,179.65 | 2019-2024 | Grafix Pl |
| Organogenesis INC. | $833.27 | 2019-2025 | Puraply Wound Matrix, Simplimax, Puraply |
| Medline Industries LP | $754.43 | 2019-2020 | |
| Bioventus LLC | $160.79 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Surgenex LLC | $99.87 | 2025 | Surgraft, Ardeograft, Renograft |
| Musculoskeletal Transplant Foundation INC. | $49.30 | 2020 | |
| Stryker Corporation | $34.84 | 2023 | Variax, Ortholoc 3di |
| Hartmann USA, INC. | $31.11 | 2023 | Zetuvit Plus |
| Evolution Surgical, INC | $29.83 | 2024 | |
| Osiris Therapeutics INC. | $28.79 | 2019 | |
| Next Science LLC | $24.69 | 2022 | |
| Ossio INC | $24.20 | 2023 | |
| Horizon Therapeutics Plc | $17.08 | 2019 | |
| Mimedx Group, INC. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adelina Stateva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.